These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 458242)

  • 21. Plasma aldosterone in patients with end stage kidney disease.
    Weidmann P; Lupu AN; Schroth P; Maxwell MH
    Proc Eur Dial Transplant Assoc; 1972; 9():147-53. PubMed ID: 4668907
    [No Abstract]   [Full Text] [Related]  

  • 22. [On dialysis therapy of chronic kidney failure].
    Alwall N
    Z Gesamte Inn Med; 1966 Sep; 21(18):Suppl:236-40. PubMed ID: 5990731
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pathogenetic participation of exchangeable sodium and plasma renin activity in the genesis and development of hypertension in patients with chronic renal insufficiency on maintenance dialysis].
    Horký K; Kapitola J; Lachmanová J; Straková M; Tomásek R; Kaslíková J
    Cas Lek Cesk; 1974 Jun; 113(24):732-40. PubMed ID: 4451960
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electrolyte studies on erythrocytes in chronic renal insufficiency prior to and following hemodialysis using diclysates with varying electrolyte concentration].
    Hagemann I; Schilling E; Precht K; Strangfeld D; Lindenau K; Kruse I; Pietsch R; Hörold I
    Z Urol Nephrol; 1976 Dec; 69(12):901-5. PubMed ID: 1014933
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenesis of hypertension in hemodialysis patients: a pharmacological study.
    Zuccalà A; Santoro A; Ferrari G; Zucchelli P
    Kidney Int Suppl; 1988 Sep; 25():S190-1. PubMed ID: 3054237
    [No Abstract]   [Full Text] [Related]  

  • 26. [Change in juxtaglomerular apparatus activity in chronic renal insufficiency in the process of hemodialysis treatment].
    Barsegian BA; Vinnitskiĭ LI; Egorova IA
    Zh Eksp Klin Med; 1978; 18(3):82-5. PubMed ID: 685604
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hyperkalemia during prolonged use of angiotensin II-converting enzyme inhibitors in end-stage renal insufficiency].
    Mooser V; Fellay G; Regamey C
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1927-9. PubMed ID: 1465596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemofiltration for long-term maintenance of patients with end stage renal disease: impact on hypertension.
    Henderson LW; Sanfelippo ML; Stone RA
    Adv Nephrol Necker Hosp; 1980; 9():21-32. PubMed ID: 6773312
    [No Abstract]   [Full Text] [Related]  

  • 29. [Proceedings: Correlations between blood pressure, body sodium/blood volume state and plasma renin in patients with terminal kidney insufficiency].
    Weidmann P; Steffen F; Beretta-Piccoli C; Blumberg A; Bühler FR; Reubi FC
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1779-80. PubMed ID: 1215976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of clonidine therapy on exchangeable sodium and renal hemodynamics in essential hypertension.
    Todesco S; Huber W; Romagnoli GF; Gambari PF; Guardini R; Borsatti A
    Arzneimittelforschung; 1974 Mar; 24(3):348-51. PubMed ID: 4407413
    [No Abstract]   [Full Text] [Related]  

  • 31. Performing only one cardiovascular reflex test has a high positive predictive value for diagnosing autonomic neuropathy in patients with chronic renal failure on hemodialysis.
    Sahin M; Kayatas M; Urun Y; Sennaroglu E; Akdur S
    Ren Fail; 2006; 28(5):383-7. PubMed ID: 16825086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma renin activity in patients with chronic nephritis.
    Kuska J; Kokot F
    Pol Med J; 1972; 11(5):1080-9. PubMed ID: 4648593
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sodium and potassium concentrations in the erythrocytes of patients undergoing chronic hemodialysis. (I)--Effects of hemodialysis on the erythrocyte sodium and potassium concentrations (author's transl)].
    Imada A; Horiuchi A; Kawauchi Y; Kogi Y
    Rinsho Byori; 1982 Jan; 30(1):82-6. PubMed ID: 7087235
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma renin activity in chronic nephropathy.
    Nielsen I; Clausen E; Jensen G
    Acta Med Scand; 1970 Nov; 188(5):351-4. PubMed ID: 5490562
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular and hormonal effects of clonidine in patients with essential hypertension and renal hypertension.
    Mathias CJ; Wilkinson AH; Stone FA; Peart S
    J Hypertens Suppl; 1985 Dec; 3(4):S73-5. PubMed ID: 3913757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of prostaglandin A2 in patients with renal insufficiency].
    Hornych A; Papanicolaou N
    Nouv Presse Med; 1974 Dec; 3(44):2628-32. PubMed ID: 4459850
    [No Abstract]   [Full Text] [Related]  

  • 38. [Differential therapeutic principles in the drug therapy of high blood pressure].
    Rahn KH
    Internist (Berl); 1974 Mar; 15(3):157-64. PubMed ID: 4151964
    [No Abstract]   [Full Text] [Related]  

  • 39. How should dialysis fluid be individualized for the chronic hemodialysis patient? Potassium.
    Rachoin JS; Weisberg LS
    Semin Dial; 2008; 21(3):223-5. PubMed ID: 18363596
    [No Abstract]   [Full Text] [Related]  

  • 40. [Change in the activity of blood plasma renin in chronic renal insufficiency during treatment with hemodialysis].
    Barsegian BA
    Ter Arkh; 1978; 50(7):127-9. PubMed ID: 715710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.